Published • loading... • Updated
DXA-Measured Body Composition Effects of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Adults with Obesity or Type 2 Diabetes: A Systematic Review and Meta-Analysis of Phase 3 Randomized Trials
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
DXA-Measured Body Composition Effects of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Adults with Obesity or Type 2 Diabetes: A Systematic Review and Meta-Analysis of Phase 3 Randomized Trials
Background Glucagon-like peptide-1 (GLP-1) and dual GIP/GLP-1 receptor agonists produce substantial weight loss in adults with obesity and type 2 diabetes (T2D), but it comprises both fat and lean tissue, and the absolute magnitude of lean body mass (LBM) loss on dual-energy X-ray abs...
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
